Different Role of Zinc Transporter 8 Between Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2016 May 17

PMID 27181765

Citations 17

Authors

Bo Yi

Gan Huang

Zhiguang Zhou

Affiliations

Soon will be listed here.

Abstract

Diabetes can be simply classified into type 1 diabetes mellitus and type 2 diabetes mellitus. Zinc transporter 8 (ZnT8), a novel islet autoantigen, is specifically expressed in insulin-containing secretory granules of β-cells. Genetic studies show that the genotypes of SLC30A8 can determine either protective or diabetogenic response depending on environmental and lifestyle factors. The ZnT8 protein expression, as well as zinc content in β-cells, was decreased in diabetic mice. Thus, ZnT8 might participate in insulin biosynthesis and release, and subsequently involved deteriorated β-cell function through direct or indirect mechanisms in type 1 diabetes mellitus and type 2 diabetes mellitus. From a clinical feature standpoint, the prevalence of ZnT8A is gradiently increased in type 2 diabetes mellitus, latent autoimmune diabetes in adults and type 1 diabetes mellitus. The frequency and epitopes of ZnT8-specific T cells and cytokine release by ZnT8-specific T cells are also different in diabetic patients and healthy controls. Additionally, the response to ZnT8 administration is also different in type 1 diabetes mellitus and type 2 diabetes mellitus. In the present review, we summarize the literature about clinical aspects of ZnT8 in the pathogenesis of diabetes, and suggest that ZnT8 might play a different role between type 1 diabetes mellitus and type 2 diabetes mellitus.

Citing Articles

Genetic Polymorphism of Zinc Transporter-8 Gene (SLC30A8), Serum Zinc Concentrations, and Proteome Profiles Related to Type 2 Diabetes in Elderly.

Sirivarasai J, Tristitworn P, Shantavasinkul P, Roytrakul S, Chansirikarnjana S, Ruangritchankul S J Clin Med. 2025; 14(3).

PMID: 39941463 PMC: 11818826. DOI: 10.3390/jcm14030790.

Maternal Metal Ion Status Along Pregnancy and Perinatal Outcomes in a Group of Mexican Women.

Vasquez-Procopio J, Torres-Torres J, Rojas-Lima E, Espino-Y-Sosa S, Solis-Paredes J, Sanchez-Martinez M Int J Mol Sci. 2024; 25(23).

PMID: 39684916 PMC: 11642521. DOI: 10.3390/ijms252313206.

The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus.

Yue M, He X, Min X, Yang H, Xu H, Wu W Front Immunol. 2024; 15:1462384.

PMID: 39380988 PMC: 11458421. DOI: 10.3389/fimmu.2024.1462384.

Relationship Between the Single Nucleotide Polymorphism rs11558471 in the SLC30A8/ZnT8 Gene and Cardiometabolic Markers in Postmenopausal Women.

da Costa S, Almeida J, Pires L, Brandao-Lima P, Rogero M, Mendes-Netto R Biol Trace Elem Res. 2022; 201(5):2183-2190.

PMID: 35793043 DOI: 10.1007/s12011-022-03337-w.

Neglected Facts on Subspecies and Type 1 Diabetes.

Ozana V, Hruska K, Sechi L Int J Mol Sci. 2022; 23(7).

PMID: 35409018 PMC: 8998319. DOI: 10.3390/ijms23073657.

References

Lemaire K, Ravier M, Schraenen A, Creemers J, Van de Plas R, Granvik M . Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci U S A. 2009; 106(35):14872-7. PMC: 2736467. DOI: 10.1073/pnas.0906587106. View

Capdor J, Foster M, Petocz P, Samman S . Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol. 2012; 27(2):137-42. DOI: 10.1016/j.jtemb.2012.08.001. View

Nielsen L, Vaziri-Sani F, Porksen S, Andersen M, Svensson J, Bergholdt R . Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity. 2011; 44(8):616-23. DOI: 10.3109/08916934.2011.576724. View

Arvan P, Pietropaolo M, Ostrov D, Rhodes C . Islet autoantigens: structure, function, localization, and regulation. Cold Spring Harb Perspect Med. 2012; 2(8). PMC: 3405822. DOI: 10.1101/cshperspect.a007658. View

Masala S, Cossu D, Piccinini S, Rapini N, Massimi A, Porzio O . Recognition of zinc transporter 8 and MAP3865c homologous epitopes by new-onset type 1 diabetes children from continental Italy. Acta Diabetol. 2014; 51(4):577-85. DOI: 10.1007/s00592-014-0558-2. View

Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D . A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445(7130):881-5. DOI: 10.1038/nature05616. View

Kawasaki E, Uga M, Nakamura K, Kuriya G, Satoh T, Fujishima K . Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia. 2008; 51(12):2299-302. DOI: 10.1007/s00125-008-1165-y. View

Wenzlau J, Juhl K, Yu L, Moua O, Sarkar S, Gottlieb P . The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007; 104(43):17040-5. PMC: 2040407. DOI: 10.1073/pnas.0705894104. View

Dang M, Rockell J, Wagner R, Wenzlau J, Yu L, Hutton J . Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol. 2011; 186(10):6056-63. PMC: 3088514. DOI: 10.4049/jimmunol.1003815. View

10.

Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier F, Carel J . Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients. Diabetologia. 2012; 55(7):2026-31. PMC: 3740540. DOI: 10.1007/s00125-012-2543-z. View

11.

Boesgaard T, Zilinskaite J, Vanttinen M, Laakso M, Jansson P, Hammarstedt A . The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia. 2008; 51(5):816-20. DOI: 10.1007/s00125-008-0955-6. View

12.

Wijesekara N, Dai F, Hardy A, Giglou P, Bhattacharjee A, Koshkin V . Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia. 2010; 53(8):1656-68. PMC: 6101216. DOI: 10.1007/s00125-010-1733-9. View

13.

Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L . The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2013; 383(9922):1084-94. DOI: 10.1016/S0140-6736(13)62219-9. View

14.

Wu X, Xu X, Gu R, Wang Z, Chen H, Xu K . Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays. Autoimmunity. 2012; 45(2):176-85. DOI: 10.3109/08916934.2011.622014. View

15.

Huang G, Xiang Y, Pan L, Li X, Luo S, Zhou Z . Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus. Diabetes Metab Res Rev. 2013; 29(5):363-8. DOI: 10.1002/dmrr.2396. View

16.

Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L . Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care. 2014; 38(1):16-21. DOI: 10.2337/dc14-1770. View

17.

Flannick J, Thorleifsson G, Beer N, Jacobs S, Grarup N, Burtt N . Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet. 2014; 46(4):357-63. PMC: 4051628. DOI: 10.1038/ng.2915. View

18.

Enee E, Kratzer R, Arnoux J, Barilleau E, Hamel Y, Marchi C . ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes. Diabetes. 2012; 61(7):1779-84. PMC: 3379659. DOI: 10.2337/db12-0071. View

19.

Xu K, Zha M, Wu X, Yu Z, Yu R, Xu X . Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes--a meta-analysis. Diabetes Res Clin Pract. 2010; 91(2):195-202. DOI: 10.1016/j.diabres.2010.11.012. View

20.

Nayak D, Calderon B, Vomund A, Unanue E . ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions. Diabetes. 2014; 63(10):3438-48. PMC: 4171664. DOI: 10.2337/db13-1882. View